| Mariya Stratilatova, MD | |
|
19 Bradhurst Ave, Suite 200n, Hawthorne, NY 10532-2140 | |
| (914) 493-7701 | |
| (914) 345-0652 |
| Full Name | Mariya Stratilatova |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 24 Years |
| Location | 19 Bradhurst Ave, Hawthorne, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750499448 | NPI | - | NPPES |
| 02820331 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 235734 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lincoln Medical & Mental Health Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Downtown Bronx Medical Associates Pc | 9638082746 | 351 |
News Archive
Queensland researchers are leading a worldwide clinical study using AI to examine COVID-19 patient data from 300 intensive care units to provide insight for health professionals to determine the best treatments for the disease.
As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).
In a post in the Chicago Council on Global Affairs' "Global Food For Thought" blog, Adam Taylor, vice president of advocacy at World Vision, writes that the Group of 20 (G20) Summit in Cannes, France, next week "provides a critical opportunity for President Obama to galvanize G20 leadership in addressing the mounting crisis of food security - the lack of reliable, nutritious food for the world's poorest people."
A recent study from Boston University School of Medicine and Boston Medical Center shows a significant decrease in severe sepsis mortality rates over the past 20 years. Looking at data from patients with severe sepsis enrolled in clinical trials, researchers found that in-hospital mortality rates decreased from 47 percent between 1991 and 1995 to 29 percent between 2006 and 2009, a time period when no new pharmacological treatments were developed for severe sepsis.
› Verified 2 days ago
| Entity Name | Downtown Bronx Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689618407 PECOS PAC ID: 9638082746 Enrollment ID: O20031106000016 |
News Archive
Queensland researchers are leading a worldwide clinical study using AI to examine COVID-19 patient data from 300 intensive care units to provide insight for health professionals to determine the best treatments for the disease.
As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).
In a post in the Chicago Council on Global Affairs' "Global Food For Thought" blog, Adam Taylor, vice president of advocacy at World Vision, writes that the Group of 20 (G20) Summit in Cannes, France, next week "provides a critical opportunity for President Obama to galvanize G20 leadership in addressing the mounting crisis of food security - the lack of reliable, nutritious food for the world's poorest people."
A recent study from Boston University School of Medicine and Boston Medical Center shows a significant decrease in severe sepsis mortality rates over the past 20 years. Looking at data from patients with severe sepsis enrolled in clinical trials, researchers found that in-hospital mortality rates decreased from 47 percent between 1991 and 1995 to 29 percent between 2006 and 2009, a time period when no new pharmacological treatments were developed for severe sepsis.
› Verified 2 days ago
| Entity Name | Harlem Medical Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487957692 PECOS PAC ID: 9335321223 Enrollment ID: O20110315000005 |
News Archive
Queensland researchers are leading a worldwide clinical study using AI to examine COVID-19 patient data from 300 intensive care units to provide insight for health professionals to determine the best treatments for the disease.
As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).
In a post in the Chicago Council on Global Affairs' "Global Food For Thought" blog, Adam Taylor, vice president of advocacy at World Vision, writes that the Group of 20 (G20) Summit in Cannes, France, next week "provides a critical opportunity for President Obama to galvanize G20 leadership in addressing the mounting crisis of food security - the lack of reliable, nutritious food for the world's poorest people."
A recent study from Boston University School of Medicine and Boston Medical Center shows a significant decrease in severe sepsis mortality rates over the past 20 years. Looking at data from patients with severe sepsis enrolled in clinical trials, researchers found that in-hospital mortality rates decreased from 47 percent between 1991 and 1995 to 29 percent between 2006 and 2009, a time period when no new pharmacological treatments were developed for severe sepsis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mariya Stratilatova, MD 19 Bradhurst Ave, Suite 200n, Hawthorne, NY 10532-2140 Ph: (914) 493-7701 | Mariya Stratilatova, MD 19 Bradhurst Ave, Suite 200n, Hawthorne, NY 10532-2140 Ph: (914) 493-7701 |
News Archive
Queensland researchers are leading a worldwide clinical study using AI to examine COVID-19 patient data from 300 intensive care units to provide insight for health professionals to determine the best treatments for the disease.
As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).
In a post in the Chicago Council on Global Affairs' "Global Food For Thought" blog, Adam Taylor, vice president of advocacy at World Vision, writes that the Group of 20 (G20) Summit in Cannes, France, next week "provides a critical opportunity for President Obama to galvanize G20 leadership in addressing the mounting crisis of food security - the lack of reliable, nutritious food for the world's poorest people."
A recent study from Boston University School of Medicine and Boston Medical Center shows a significant decrease in severe sepsis mortality rates over the past 20 years. Looking at data from patients with severe sepsis enrolled in clinical trials, researchers found that in-hospital mortality rates decreased from 47 percent between 1991 and 1995 to 29 percent between 2006 and 2009, a time period when no new pharmacological treatments were developed for severe sepsis.
› Verified 2 days ago
Dr. Amy Michelle Wasserman, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave, Suite 3070n, Hawthorne, NY 10532 Phone: 914-372-7887 Fax: 914-372-7884 | |
Karim Bakash Solangi, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 19 Bradhurst Ave, Suite 200n, Hawthorne, NY 10532 Phone: 914-493-7701 Fax: 914-345-0652 | |
Carmelo Anthony Puccio, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave, Suite 2100, Hawthorne, NY 10532 Phone: 914-493-8375 Fax: 914-347-1832 | |
Dr. Joseph Vozzolo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave, Suite 700, Hawthorne, NY 10532 Phone: 914-337-3500 | |
Dr. Sei Iwai, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave, Suite 3850s, Hawthorne, NY 10532 Phone: 914-909-6900 Fax: 914-909-2828 | |
Michael Paul Fanucchi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 19 Bradhurst Ave Ste 2300n, Hawthorne, NY 10532 Phone: 914-909-9018 Fax: 914-493-2416 | |
Dr. George Thomas Mathew, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 500 Sherman Ave, Hawthorne, NY 10532 Phone: 262-442-7948 |